abstract |
Disclosed is the compound(2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide. The use of the above compound for the manufacture of a medicament for treating Alzheimer's disease, cerebral amyloid angipathy, mild cognitive impairment and/or Down syndrome is also disclosed. The process for preparing the said compound, as well as its intermediates, is also disclosed. |